| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $126.2M | +11.1% |
| Cost of Revenue | $66.0M | +21.0% |
| Gross Profit | $60.2M | +2.0% |
| R&D Expense | $11.1M | +4.4% |
| SG&A Expense | $57.1M | +10.1% |
| Operating Income | -$8.0M | -130.6% |
| Interest Expense | $2.8M | -38.1% |
| Pre-tax Income | -$10.7M | -34.0% |
| Income Tax | $2.6M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.5M | +45.9% |
| Accounts Receivable | $32.1M | +32.9% |
| Inventory | $18.2M | +41.7% |
| Current Assets | $87.9M | +35.7% |
| Total Assets | $229.9M | +10.1% |
| Current Liabilities | $44.3M | +23.4% |
| Long-term Debt | $24.2M | -14.9% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.0M | -156.7% |
| Investing Cash Flow | -$3.4M | -3.0% |
| Financing Cash Flow | $16.2M | +510.8% |
| +151.2% |
| Net Income | -$13.3M | -47.5% |
| EPS (Basic) | -$0.52 | -13.0% |
| Total Liabilities |
| $85.0M |
| +9.7% |
| Stockholders' Equity | $92.1M | +16.3% |